2017, Number 2
Multidisciplinary management of central nervous system metastases in patients with cervical carcinoma
PDF size: 285.36 Kb.
ABSTRACTObjective: To describe Central Nervous System metastases from cervical cancer experience, of a referral hospital center in Mexico, and the comparison to other published cases.
Methods: We reviewed all patients files with Cervical Cancer treated at our referral center, from May 2009 to August 2015.
Results: We found 28 patients with Cervical Cancer and Central Nervous System metastases. Mean interval between initial Cervical Cancer and CNSm: 46 months; 57% of patients had lung metastases at the time of CNSm were diagnosed. Headache was the most common symptom, followed by altered mental status, focal weakness and persisting nausea/vomiting. We compared our findings with other 124 found in the literature.
Conclusion: The present study describes the largest series of patients with Central Nervous System metastases from Cervical Cancer, this rare complication should be suspected in patients with Cervical Cancer that present neurological symptom.
Coronel J, Cetina L, Pacheco I, Trejo-Becerril C, Gonzalez-Fierro A, de la Cruz-Hernandez E, et al. A double-blind, placebo-controlled, randomized phase III trial of chemotherapy plus epigenetic therapy with hydralazine valproate for advanced cervical cancer. Preliminary results. Medical oncology. 2011;28 Suppl 1:S540-6.